Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30

$6.39−0.13 (-1.99%)

Close on Nov 13, 2026Market cap $856.72MP/E –Yield –

Immatics gross margin

Gross margin is gross profit as a percentage of revenue.

Immatics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?